Clinical Trial: An Exploratory Study on the Prevention of Insulin Resistance in Patients with Schizophrenia Spectrum Disorders Treated with Olanzapine by N-Acetylcysteine (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Exploratory Study on the Prevention of Insulin Resistance in Patients with Schizophrenia Spectrum Disorders Treated with Olanzapine by N-Acetylcysteine'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133532

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: Beijing An Ding Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=284813

Published by HT Digital Content Services with permission from Health Daily Digest....